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matrix, which is regulated by matrix metalloproteinases (MMPs). However, changes in
MMPs associated with AF have not been described previously.
Methods and Results: Left atrial myocardium was obtained from explanted hearts of 16
patients (pts) with heart failure (CHF) undergoing transplantation. A history of persistent
AF was present in 6 pts and the remaining 10 pts served as non-AF controls. Plasma
samples were obtained from 16 separate pts without CHF, including 6 undergoing cardio-
version for persistent AF and 10 controls matched for age, gender, left ventricular size
and function. Myocardial MMP-2 and –9 levels, two MMP species implicated in cardiac
remodeling, were determined by zymography and plasma MMP-2 and -9 levels were
measured using enzyme linked immunosorbent assays (Table, *p<0.05 vs. non-AF).
MMP-9 levels were increased in both the myocardium and the plasma in AF pts, whereas
myocardial and plasma MMP-2 levels were similar between groups.
Conclusions: AF is associated with alterations in the myocardial and plasma levels of
the same MMP species, despite evaluating 2 very different pt populations. These findings
suggest that changes in plasma MMP levels may provide a biomarker to detect atrial
structural changes associated with AF.
1014-226 Measurement of Atrial Function Before and Immediately 
After Cardioversion for Atrial Fibrillation Using a 
Combined Transesophageal Probe for Cardioversion 
and Echocardiography
Marcoen F. Scholten, Luc J. Jordaens, Jos R. Roelandt, Paul A. Tunick, Itzhak Kronzon, 
Erasmus Medical Center, Rotterdam, The Netherlands, New York University School of 
Medicine, New York, NY
Background: Early cardioversion (ECV) after exclusion of a clot by transesphageal
echocardiography (TEE) is a proven strategy. Transesophageal cardioversion (TEC) has
been studied previously and is safe and efficacious. Combining TEE and TEC has the
potential benefit of single need for sedation and offers the opportunity to study left atrial
(LA), transmitral and LA appendage (LAA) flow during and immediately after ECV.
Methods: A custom-made combined TEC and TEE probe was used. After sedation with
weight adjusted Diazepam TEE was done. Measurements of pulmonary vein (PV) flow,
LAA emptying velocity and transmitral flow were done. Presence of clot or spontaneous
echo contrast (smoke) was scored. After exclusion of clot TEC was done after weight
adjusted Ethomidate and using a step up protocol 20-30-50 Joules biphasic shock. All
echocardiographic measurements were repeated 1 and 5 minutes after ECV.
Results: 20 Patients were included in this study (6 female, mean age 63 y (37-80y),
mean BSA 1.81 m2 (1.61-2.60m2)). The duration of AF was unknown in most patients
and in none clot was seen before TEC. Mean LA dimension 49.4 mm (SD 7.07). Sinus
rhythm was achieved in 19/20 patients. Mean transmitral peak E wave velocity decreased
from 73.2 cm/s, to 67.4 cm/s and 65.9 cm/s. Mean peak A wave velocity 33.9 cm/s (17-55
cm/s) at 1 min., and 37.1 cm/s (20-75 cm/s) at 5 min..4 patients had no A wave at 1 min,
and 2 had no A wave at 5 min despite sinus rhythm. Mean peak LAA velocity decreased
from 40.4 cm/s to 29.6 cm/s at 1 min. and to 27.6 cm/s at 5 min. after TEC. In 3/20
patients smoke was present before TEC andSmoke appeared in 8/20 patients immedi-
ately after ECV.
Conclusion: Combining TEE and TEC is efficacious and allows to study intra-atrial flow
during and after ECV. Atrial stunning was obvious despite the use of very low energy. The
appearance of smoke in a significant proportion of patients underlines the necessity of
anticoagulation after cardioversion.
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1015-215 Improved Electrocardiographic Detection of Left 
Ventricular Hypertrophy in Women: Validation by 
Cardiovascular Magnetic Resonance
Michael L. Chuang, Yoram Ariel, Carol J. Salton, Kraig V. Kissinger, Patricia A. Arand, 
Lois A. Goepfert, Robert A. Warner, Warren J. Manning, Beth Israel Deaconess Medical 
Center, Boston, MA, Inovise Medical, Inc, Newberg, OR
Sensitivity of the ECG for left venticular hypertrophy (LVH) is poor when compared to
echocardiography, but echo accuracy is decreased with poor echo windows or distorted
ventricular shape. To more accurately assess ECG performance, we compared the ECG
to volumetric cardiovascular magnetic resonance (CMR) and investigated whether using
multiple gender-specific ECG criteria improves LVH detection in women.
METHODS: 192 consecutive patients (70 women, 122 men, 50±15 years), underwent
12-lead ECG and contiguous multislice SSFP CMR (TR=3.2ms, TE=1.6ms, FA=60º,
1.92-mm2 x10mm voxels, 1.5-T Philips). Patients were classified as LVH+ or LVH- based
on published CMR criteria (LV mass index >=74.7 g/m2, women; >=95.0 g/m2, men).
Multiple ECG criteria for LVH were compared to CMR, including Sokolow-Lyon (SL); gen-
der-specific Cornell Voltage (CV) and Cornell Product (CP); 3 commerical algorithms
(C1, C2, C3); and an algorithm (Audicor) using multiple gender specific LVH criteria.
RESULTS: Prevalence of CMR LVH was 13% in women and 23% in men (p=NS). The
Table shows ECG sensitivity, specificity and positive and negative predictive values
(Sens, Spec, PPV, NPV, %) by gender.
CONCLUSION: Commonly used ECG algorithms have high specificity regardless of gen-
der but modest sensitivity for LVH in men and poor sensitivity in women. Use of multiple
gender-specific ECG criteria (Audicor) for LVH improves sensitivity in women to a level
comparable to that for men while maintaining high specificity and superior PPV and NPV.
1015-216 ST Depression Versus T Wave Amplitude on the Resting 
Electrocardiogram: Which Is the Better Predictor of 
Cardiovascular Mortality?
James Beckerman, Takuya Yamazaki, Jonathan Myers, Sung Chun, Paul Wang, Victor 
Froelicher, Stanford University, Stanford, CA, VA Palo Alto Health Care System, Palo 
Alto, CA
Background: ST depression and T wave amplitude abnormalities are known to be inde-
pendent predictors of cardiovascular death, but a direct comparison between them has
not been described.
Methods: Analyses were performed on the first electrocardiogram digitally recorded on
46,950 consecutive patients at the Palo Alto Veterans Affairs Medical Center since 1987.
Females and patients with electrocardiograms exhibiting bundle branch block, left ven-
tricular hypertrophy, electronic pacing, diagnostic Q waves, or Wolff-Parkinson-White
syndrome were excluded, leaving 31,074 male patients for analysis (mean age 55 ± 14).
There were 1,878 (6.0%) cardiovascular deaths (mean follow-up of 6 ± 4 years). Electro-
cardiograms were classified using Minnesota code according to degree of ST depression
and T wave abnormality, and the nine possible combinations of ST segment and T wave
abnormalities were recoded for analysis.
Results: After adjusting for age and heart rate in a Cox regression model, the combina-
tion of major abnormalities in ST segments and T waves carried the greatest hazard (3.2
[CI 2.7-3.8]). Minor ST depression combined with more severe T wave abnormalities car-
ried a hazard of 3.1 (CI 2.5-3.7), whereas minor T wave abnormalities combined with
more severe ST depression carried a hazard of only 1.9 (CI 1.6-2.3).
Conclusion: While both ST segment depression and abnormal T wave amplitude are
clinically important, T wave abnormalities appear to be more highly associated with car-
diovascular mortality.
1015-217 Holter-Based Risk Stratifiers May Increase Cost-
Effectiveness of Defibrillator Therapy in MADIT II-Like 
Patients
Dan Wichterle, Jan Simek, John Camm, Marek Malik, General University Hospital, 
Prague, Czech Republic, St. George's Hospital Medical School, London, United Kingdom
Background: Both prevalent low-frequency oscillation of heart rate (PLF) and turbulence
slope (TS) are powerful postinfarction risk stratifiers. We investigated the predictive
power of their combination in the subpopulation of placebo arm of EMIAT trial defined by
LVEF < 30%.
Methods: PLF and TS were calculated by standard methods. Cut-off values of PLF > 0.1
Hz and TS < 2.5 ms/RR were used as previously established. Two composite risk stratifi-
Mean±SD. IOD: Integrated Optical Density
Myocardium (IOD) Plasma (ng/mL)
Non-AF AF Non-AF AF
MMP-2 68±24 83±11 1251±373 1183±278
MMP-9 29±12 51±22* 22±14 80±54*
ECG vs. CMR LVH
SL CV CP C1 C2 C3 Audicor
Women: Sens/Spec 11/95 11/90 11/100 11/95 0/95 22/92 44/92
Men: Sens/Spec 50/85 33/99 61/90 46/82 46/81 68/82 54/90
Women: PPV/NPV 25/88 14/87 100/88 25/88 0/87 29/89 44/92
Men: PPV/NPV 50/85 91/84 65/89 43/84 42/84 53/90 63/87
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ers (CRS-1 and CRS-2) were investigated. Abnormal CRS-1 was defined as abnormal
PLF or abnormal TS only when PLF was not analysable. Abnormal CRS-2 was defined
as abnormal TS or abnormal PLF only when TS was not analysable. 
Results: There were 295 patients with LVEF < 30% in the placebo arm of EMIAT trial of
those 57 died during mean follow-up of 22 months. The mortality of 19.3% was compara-
ble to that in conventional-therapy group in MADIT II trial (19.8%). Prediction results are
shown in the Table. CRS-1 stratification associated with sensitivity of 49% would reduce
the costs of defibrillator therapy to 23%. CRS-2 stratification associated with sensitivity of
68% would reduce the costs of defibrillator therapy to 39%.
Conclusion: As MADIT II indication criteria for defibrillator therapy are not fully imple-
mented due to the lack of financial resources, the selection of patients at the highest risk
with acceptable sensitivity using Holter-based risk stratifiers might be of considerable
clinical value.
1015-218 Value of Electrocardiographic Parameters in Identifying 
Patients With a Mild Form of Arrhythmogenic Right 
Ventricle Dysplasia
Khurram Nasir, Chandra Bomma, Darshan Dalal, Daniyal Ahmed, HariKrishna Tandri, 
Ariel Roguin, Cynthia James, Crystal Tichnell, Hugh Calkins, Johns Hopkins Medical 
Institutions, Baltimore, MD
Background: Although overt forms of ARVD are easily identified, it is difficult to differen-
tiate patients with a mild form of ARVD who have minimal involvement of the right ventri-
cle from those with idiopathic ventricular tachycardia (IVT). The aim of our study was to
identify electrocardiographic (ECG) criteria that best distinguish early ARVD from IVT.
Methods & Results: After excluding 19 patients with diffuse ARVD, the study population
consisted of 48 consecutive patients who presented with left bundle branch block (LBBB)
VT. Localized ARVD (n=20) was diagnosed based on the presence of regional RV
lesions, such as segmental RV wall motion abnormalities (hypo-akinetic or dyskinetic
areas), with mild or no ejection fraction reduction, whereas IVT (n=30) was classified
based on the exclusion of structural heart disease. Patients with localized ARVD com-
pared to IVT had a greater QRS duration in V1-V3 (113±14 vs.99±12 ms, p=0.0004), S
wave upstroke duration in V1-V3 (57±10 vs. 37±9 ms, p<0.0001), QRS dispersion (33±9
vs. 24±11 ms, p<0.02), and QT dispersion (67±18 vs. 37±14 ms, p<0.0001). The relative
prevalence of ECG abnormalities in these two conditions is shown in the table. An S
wave upstroke duration >55 ms in V1-V3 had the highest diagnostic value with a Chi-
square value of 36.7.
Conclusion: A delayed S wave upstroke in V1-V3 is the ECG parameter which best dif-
ferentiates mild ARVD from IVT, and might be considered as diagnostic ECG criteria for
ARVD.
1015-219 The Influence of Atrial and Ventricular Pacing on T Wave 
Alternans
Aneesh V. Tolat, Matthew R. Reynolds, Panos Papageorgiou, Allison W. Richardson, 
Peter Zimetbaum, Mark E. Josephson, Beth Israel Deaconess Medical Center, Boston, 
MA
Background: T Wave Alternans (TWA) is a novel technique of risk stratification for sud-
den cardiac death. Exercise and atrial pacing have been studied with regards to their
influence on TWA. In the present study, we investigated the differential effect of atrial and
atrioventricular pacing on TWA outcome (TWA-O) and TWA magnitude (TWA-M) and
examined their correlation with outcome of standard electrophysiology study (EPS) in
patients with coronary disease and left ventricular dysfunction. 
Methods: Atrial and atrioventricular pacing at 5 rates (80, 90, 100, 110, 115 bpm) for 1.5
minutes was performed followed by EPS in 34 patients with a history of coronary disease
and mean ejection fraction 28% referred for risk stratification. A Cambridge Heart, Heart-
wave system was used to analyze TWA-O (+ or - ) according to standard guidelines.
TWA analysis was based on recordings from 6 precordial leads and 4 orthogonal leads.
Results: Atrioventricular pacing resulted in higher TWA-M when compared to atrial pac-
ing alone, but both sites yielded similar TWA-O (p=0.02; Sign Test; kappa=0.61). Mono-
morphic ventricular tachycardia was inducible in 20/34 patients. TWA was positive in 16
patients during atrial pacing and in 13 patients during atrioventricular pacing but TWA-O
did not correlate with EPS outcome. The ECG lead distribution of TWA was independent
of pacing site. Leads V2-V4 demonstrated 100% sensitivity for positive TWA
Conclusion: 1. Increased TWA-M during ventricular pacing suggests that ventricular
pacing may be proarrhythmic. 2. TWA and EPS measure different indices of electrical
instability and could be used in combination. 3. The use of the anterior precordial leads
may allow for a simplified approach in recording TWA. 4. Ventricular pacing may be alter-
native method to assess TWA in patients with atrial fibrillation. 
1015-220 Prevalence and Prognostic Implications of Transient ST-
Segment Elevation Early After Primary Angioplasty for 
ST-Segment Elevation Myocardial Infarction
Dan E. Hofsten, Kenneth Egstrup, Birgit Lund, Henning Molgaard, for the DANAMI-2 
investigators, Svendborg Hospital, Svendborg, Denmark, Skejby Sygehus, Aarhus 
University Hospital, Aarhus, Denmark
Background:Episodes of transient ST-segment elevation (STe) on Holter monitoring has
been associated with increased mortality after ST-segment elevation myocardial infarc-
tion (STEMI). However, previous studies all antedate the advent of primary angioplasty
(PA).
We compared the prevalence and prognostic implications of STe, detected early after
STEMI treated with fibrinolysis or PA respectively.
Methods: Holter monitoring was initiated at discharge from STEMI in 951 patients who
had been randomized to immediate revascularization with either fibrinolysis (n = 473) or
PA (n = 478) as part of the DANAMI-2 study. Significant STe was defined as an upward
shift of the ST segment > 0.2 mV in magnitude that lasted > 1 minute. Follow-up ranged
from 2 to 5 years. Primary end point was all-cause mortality.
Results:In the fibrinolysis group 48 (10.1%) had STe as compared to 26 (5.4%) in the PA
group (p = 0.007). Mortality in the fibrinolysis group was significantly higher among
patients with STe (hazard ratio: 4.1; p < 0.0001), and in a stepwise multivariate Cox
regression analysis incorporating clinical and investigational variables, STe was indepen-
dently correlated to outcome (p < 0.001). In the PA group however, none of the patients
with STe on Holter monitoring died during follow-up.
Conclusion: Immediate revascularization with PA in STEMI reduces the incidence of
subsequent STe as compared to fibrinolysis. Furthermore, unlike in fibrinolysed patients,
STe is not associated with increased mortality after PA. 
1015-221 Speed of QT Rate Adaptation Predicts Risk in 
Myocardial Infarction Survivors
Peter Smetana, Esther Pueyo, Katerina Hnatkova, Velislav Batchvarov, Marek Malik, St. 
George's Hospital Medical School, London, United Kingdom
Background: Descriptors of QT/RR relationship were reported repeatedly to provide
information superior to simple QTc interval. We therefore investigated the exact profile of
QT adaptation to changes in RR interval in Holter recordings of patients from the EMIAT
database.
Methods: In 866 (462 amiodarone (A), 404 placebo (P)) 24-hour Holter recordings
obtained 1 month after randomisation into EMIAT RR, and QT intervals were measured
automatically on a beat-to-beat basis using a commercial Holter system. The individual
QT rate adaptation profile was assessed on a continuous basis quantifying the weighted
impact of RR interval history on each measured QT interval. The speed of adaptation
was assessed by the so-called lambda factor (LF). The smaller the LF, the faster the QT/
RR adaptation (figure). The values of the LF were compared between survivors and
Prediction of all-cause mortality using CRS-1 and CRS-2
 CRS-1  CRS-2
 abnormal  normal  abnormal  normal
non-survivors
(absolute numbers) 28 29 39  18
survivors (absolute numbers)
 41  197  75  163
sensitivity (%)
 49.1 68.4
positive predictive value (%)
40.6 34.2
ECG Characteristics of ARVD vs. Idiopathic Ventricular Tachycardia
Localized 
ARVD
n=20
Idiopathic 
VTn=28
P value Ch- Square 
value
T wave inversion V1-V3 and 
beyond
14 (70%) 0 (-) <0.0001 27.6
Epsilon wave 3 (15%) 0 (-) 0.03 3.8
QRS>110 V1-V3 ms 10 (50%) 0 (-) <0.0001 17.7
QRS V1+V2+V3/ QRSd 
V4+V5+V6>1.2
12 (60%) 2 (7%) <0.0001 15.7
QRS dispersion>40 ms 7 (35%) 1 (4%) 0.004 8.3
QT dispersion>65 ms 12 (60%) 3 (10%) <0.0001 8.3
S wave upstroke>55 V1-V3 ms 18 (90%) 1 (4%) <0.0001 36.7
